Sign in to view content

Progression of diabetic retinopathy in patients treated with 0.2 μg/day

Raymond Iezzi, MD, MS

Video
Published 2017

Related

Five-Year Outcomes After Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T)
Dante Joseph Pieramici, MD
Annual Meeting Talks
2020
A Model to Predict the 3-Year Risk of Needing Treatment for Diabetic Macular Edema
Bobeck S Modjtahedi, MD
Annual Meeting Talks
2018
Novel fixation technique allows for in situ imaging of extracellular vesicles (EVs), revealing a dense network of functional EVs in the vitreous humor
Mrinali Gupta, MD, FASRS
Updates from the Field
2020

Category: Diabetic Retinopathy

See more